A woman from WA has become the second Australian to suffer a rare blood clotting condition after receiving the AstraZeneca vaccine.
The woman aged in her 40s is in a stable condition in hospital after being diagnosed with a case of “thrombosis with thrombocytopenia”.
The Therapeutic Goods Administration (TGA) issued a statement on Tuesday and said the case is "likely to be linked to the vaccination".
"The panel concluded that the case is similar to cases seen in Europe and the United Kingdom of a rare clotting disorder, referred to as 'thrombosis with thrombocytopenia syndrome' (TTS)."
There have been about 700,000 doses of AstraZeneca vaccines administered in Australia to date.
The second case now means one in 350,000 AstraZeneca vaccinations administered in the country have potential ties to blood clots.
"The TGA is carefully reviewing all Australian reports of blood clots following the AstraZeneca vaccine," the statement read.
People who have received the vaccine should seek immediate medical attention if they develop symptoms such as a severe or persistent headache, blurred vision, shortness of breath, chest pain, leg swelling or unusual skin bruising and/or pinpoint round spots beyond the site of injection.
Digital drivers' licences to be introduced in WA
Mandurah FIFO worker wins $250k
2026 ANZAC Day services across the Peel and Rockingham regions
Mother of 11-year-old boy killed in Mandurah scooter crash found safe and well
Peel charity desperately seeks funds to keep doors open
Australind train service set to resume
Thunder premiership player Traye Bennell hangs up the boots
Works underway to protect 200-year-old 'Big Tree' in Greenfields
Wanted man believed to be in Mandurah area